Management of Newly Diagnosed Symptomatic Multiple Myeloma: updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Guidelines

J.A. Pérez-Simón, R. Garcı́a-Sanz, M.D. Tabernero, J. Almeida, M. González, J. Fernández-Calvo, M.J. Moro, J.M. Hernández, J.F. San Miguel, A. Orfão, Prognostic Value of Numerical Chromosome Aberrations in Multiple Myeloma: A FISH Analysis of 15 Different Chromosomes Blood. ,vol. 91, pp. 3366- 3371 ,(1998) , 10.1182/BLOOD.V91.9.3366

Michelle M. Bishop, Helen Welsh, Mary Coons, John R. Wingard, Blood and Marrow Transplantation Biopsychosocial Perspectives on Transplantation. pp. 19- 37 ,(2001) , 10.1007/978-1-4615-1333-9_2

Jean-Paul Fermand, Philippe Ravaud, Sylvie Chevret, Marine Divine, Véronique Leblond, Coralie Belanger, Margaret Macro, Edouard Pertuiset, François Dreyfus, Xavier Mariette, Catherine Boccacio, Jean-Claude Brouet, High-dose therapy and autologous peripheral blood stem cell transplantation in multiple myeloma: up-front or rescue treatment? Results of a multicenter sequential randomized clinical trial. Blood. ,vol. 92, pp. 3131- 3136 ,(1998) , 10.1182/BLOOD.V92.9.3131

A Riccardi, O Mora, C Tinelli, D Valentini, S Brugnatelli, R Spanedda, A De Paoli, L Barbarano, M Di Stasi, M Giordano, C Delfini, G Nicoletti, C Bergonzi, E Rinaldi, L Piccinini, E Ascari, Long-term survival of stage I multiple myeloma given chemotherapy just after diagnosis or at progression of the disease: a multicentre randomized study British Journal of Cancer. ,vol. 82, pp. 1254- 1260 ,(2000) , 10.1054/BJOC.1999.1087

Meral Beksac, Rauf Haznedar, Tulin Firatli‐Tuglular, Hakan Ozdogu, Ismet Aydogdu, Nahide Konuk, Gulsan Sucak, Işık Kaygusuz, Sema Karakus, Emin Kaya, Ridvan Ali, Zafer Gulbas, Gulsum Ozet, Hakan Goker, Levent Undar, None, Addition of thalidomide to oral melphalan/prednisone in patients with multiple myeloma not eligible for transplantation: results of a randomized trial from the Turkish Myeloma Study Group. European Journal of Haematology. ,vol. 86, pp. 16- 22 ,(2011) , 10.1111/J.1600-0609.2010.01524.X

BG Durie, SE Salmon, TE Moon, Pretreatment tumor mass, cell kinetics, and prognosis in multiple myeloma. Blood. ,vol. 55, pp. 364- 372 ,(1980) , 10.1182/BLOOD.V55.3.364.364

Raman Desikan, Bart Barlogie, Jeffrey Sawyer, Dan Ayers, Guido Tricot, Ashraf Badros, Maurizio Zangari, Nikhil C. Munshi, Elias Anaissie, Dan Spoon, David Siegel, Sundar Jagannath, David Vesole, Joshua Epstein, John Shaughnessy, Athanasios Fassas, Seah Lim, Paula Roberson, John Crowley, Results of high-dose therapy for 1000 patients with multiple myeloma: durable complete remissions and superior survival in the absence of chromosome 13 abnormalities. Blood. ,vol. 95, pp. 4008- 4010 ,(2000) , 10.1182/BLOOD.V95.12.4008

Philip R. Greipp, Gordon W. Dewald, Scott A. Van Wier, S. Vincent Rajkumar, Martin M. Oken, Emily A. Blood, David Harrington, Kimberly J. Henderson, Neil E. Kay, Brian Van Ness, Rafael Fonseca, Richard J. Bailey, Biological and Prognostic Significance of Interphase Fluorescence in Situ Hybridization Detection of Chromosome 13 Abnormalities (Δ13) in Multiple Myeloma: An Eastern Cooperative Oncology Group Study Cancer Research. ,vol. 62, pp. 715- 720 ,(2002)

PR Greipp, JA Lust, WM O'Fallon, JA Katzmann, TE Witzig, RA Kyle, Plasma cell labeling index and β2-microglobulin predict survival independent of thymidine kinase and C-reactive protein in multiple myeloma Blood. ,vol. 81, pp. 3382- 3387 ,(1993) , 10.1182/BLOOD.V81.12.3382.3382

S. V. Rajkumar, S. Jacobus, N. Callander, R. Fonseca, D. Vesole, M. Williams, R. Abonour, D. Siegel, P. Greipp, Phase III trial of lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone in newly diagnosed multiple myeloma (E4A03): A trial coordinated by the Eastern Cooperative Oncology Group Journal of Clinical Oncology. ,vol. 25, ,(2007) , 10.1200/JCO.2007.25.18_SUPPL.LBA8025